Founder Mode: Jen Herbach, Founder & CEO, Adventris Pharmaceuticals
The Social Radars
00:00
Where Adventris Stands: IND and Clinical Timeline
Jen shares plans to finalize the product, submit an IND to the FDA, and dose first patients in early 2027.
Transcript
Play full episode
